{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:33:55Z","timestamp":1770521635237,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dietary supplements sold for anabolic benefits or performance enhancement often contain substances, which are non-approved and might lack quality controls. With regard to athletes, the inclusion of substances or methods in the prohibited list of the World Anti-Doping Agency is based on medical or scientific evidence. 5\u03b1-hydroxy-laxogenin is a synthetic spirostane-type steroid, which is contained in dietary supplements and advertised as anabolic agent. To date, evidence is missing on anabolic or androgenic activity of 5\u03b1-hydroxy-laxogenin. We investigated its androgenic potential in two in vitro bioassays. While no activity was observed in the yeast androgen screen, 5\u03b1-hydroxy-laxogenin was able to trans-activate the androgen receptor in human prostate cells in a dose-dependent manner. Interestingly, a biphasic response was observed with antagonistic properties at lower concentrations and agonistic effects at higher concentrations tested. The demonstrated androgenic properties of the higher concentrations demonstrate that further investigations should focus on the safety as well as on potential anabolic effects of 5\u03b1-hydroxy-laxogenin. This is of interest with regard to abuse for doping purposes.<\/jats:p>","DOI":"10.1007\/s00204-022-03283-5","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T12:08:42Z","timestamp":1648469322000},"page":"2139-2142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Androgenic properties of the dietary supplement 5\u03b1-hydroxy-laxogenin"],"prefix":"10.1007","volume":"96","author":[{"given":"Carolin","family":"Beer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2157-4711","authenticated-orcid":false,"given":"Annekathrin M.","family":"Keiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"3283_CR1","first-page":"557","volume":"83","author":"A Akahori","year":"1963","unstructured":"Akahori A, Yasuda F (1963) Laxogenin, a new steroidal sapogenin isolated from Smilax sieboldi Miq. Yakugaku Zasshi 83:557\u2013558","journal-title":"Yakugaku Zasshi"},{"key":"3283_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpba.2018.12.045","volume":"167","author":"B Avula","year":"2019","unstructured":"Avula B, Chittiboyina AG, Bae J-Y et al (2019) The power of hyphenated chromatography-Time of flight mass spectrometry for unequivocal identification of spirostanes in bodybuilding dietary supplements. J Pharm Biomed Anal 167:74\u201382. https:\/\/doi.org\/10.1016\/j.jpba.2018.12.045","journal-title":"J Pharm Biomed Anal"},{"key":"3283_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1248\/bpb.23.660","volume":"23","author":"M Baba","year":"2000","unstructured":"Baba M, Ohmura M, Kishi N et al (2000) Saponins isolated from Allium chinense G. Don and antitumor-promoting activities of isoliquiritigenin and laxogenin from the same drug. Biol Pharm Bull 23:660\u2013662. https:\/\/doi.org\/10.1248\/bpb.23.660","journal-title":"Biol Pharm Bull"},{"key":"3283_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2818","volume":"3","author":"PA Cohen","year":"2020","unstructured":"Cohen PA, Sharfstein J, Kamugisha A, Vanhee C (2020) Analysis of ingredients of supplements in the national institutes of health supplement database marketed as containing a novel alternative to anabolic steroids. JAMA Netw Open 3:e202818. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2818","journal-title":"JAMA Netw Open"},{"key":"3283_CR5","unstructured":"Endocrine Disruptor Screening and Testing Advisory Committee (1998) Final Report\u2014Appendix M: Assays not Included in Tier 1 Screening. United States Environmental Protection Agency"},{"key":"3283_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/taap.1996.8069","volume":"143","author":"KW Gaido","year":"1997","unstructured":"Gaido KW, Leonard LS, Lovell S et al (1997) Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol 143:205\u2013212. https:\/\/doi.org\/10.1006\/taap.1996.8069","journal-title":"Toxicol Appl Pharmacol"},{"key":"3283_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF02876875","volume":"14","author":"CM Kim","year":"1991","unstructured":"Kim CM, Son KH, Kim SH, Kim HP (1991) Steroidal sapogenin contents in some domestic plants. Arch Pharm Res 14:305. https:\/\/doi.org\/10.1007\/BF02876875","journal-title":"Arch Pharm Res"},{"key":"3283_CR8","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/0031-9422(92)83296-b","volume":"31","author":"S Kubo","year":"1992","unstructured":"Kubo S, Mimaki Y, Sashida Y et al (1992) Steroidal saponins from the rhizomes of Smilax sieboldii. Phytochemistry 31:2445\u20132450. https:\/\/doi.org\/10.1016\/0031-9422(92)83296-b","journal-title":"Phytochemistry"},{"key":"3283_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phytochem.2012.12.001","volume":"88","author":"G Timit\u00e9","year":"2013","unstructured":"Timit\u00e9 G, Mitaine-Offer A-C, Miyamoto T et al (2013) Structure and cytotoxicity of steroidal glycosides from Allium schoenoprasum. Phytochemistry 88:61\u201366. https:\/\/doi.org\/10.1016\/j.phytochem.2012.12.001","journal-title":"Phytochemistry"},{"key":"3283_CR10","unstructured":"U.S. Food and Drug Administration (2021) Dietary Supplement Ingredient Advisory List. https:\/\/www.fda.gov\/food\/dietary-supplement-products-ingredients\/dietary-supplement-ingredient-advisory-list. Accessed 8 Feb 2022"},{"key":"3283_CR11","unstructured":"World Anti-Doping Agency (2021) World Anti-Doping Code"},{"key":"3283_CR12","unstructured":"World Anti-Doping Agency (2022) Prohibited List. World Anti-Doping Code, International Standard"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-022-03283-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T07:04:03Z","timestamp":1653894243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-022-03283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1007\/s00204-022-03283-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}